SI-BONE, Inc.

Nasdaq SIBN · Santa Clara, CA

Works in Metabolic & endocrine · Musculoskeletal

SI-BONE, Inc. is a clinical trial sponsor based in Santa Clara, CA, listed as Nasdaq SIBN. It has 5 active clinical trials with 1,550 planned participants, in Metabolic & endocrine and Musculoskeletal. Since 2021 it has completed 2 trials and stopped 1 early. Its FDA record on file shows 1 recall.

Trial track record · since 2021

5Active trials1,550 planned participants
2Completed0 with results posted
1Stopped earlyterminated, withdrawn or suspended

FDA record

0InspectionsNone posted since 2025
0Warning lettersNone on file
1RecallLatest 2026-10-21: Class II

Recent FDA actions

Financials · Nasdaq SIBN

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Pipeline · 5 active trials

StageTrialStatus

Questions about SI-BONE, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-02.

The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.

Approve Suite is not affiliated with SI-BONE, Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.